Jane Street’s RAPTOR PHARMACEUTICAL CORP COM STK (DE) RPTP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-14,050
Closed -$75K 4980
2016
Q2
$75K Buy
+14,050
New +$72K ﹤0.01% 3924
2016
Q1
Sell
-10,625
Closed -$55K 5124
2015
Q4
$55K Sell
10,625
-6,459
-38% -$37.5K ﹤0.01% 3866
2015
Q3
$103K Sell
17,084
-208,357
-92% -$2.55M ﹤0.01% 3354
2015
Q2
$3.56M Sell
225,441
-238,370
-51% -$2.9M 0.02% 647
2015
Q1
$5.04M Buy
463,811
+450,828
+3,472% +$4.6M 0.04% 398
2014
Q4
$137K Sell
12,983
-81,953
-86% -$801K ﹤0.01% 2303
2014
Q3
$910K Sell
94,936
-289,968
-75% -$2.96M 0.01% 991
2014
Q2
$4.45M Buy
384,904
+371,664
+2,807% +$3.38M 0.06% 278
2014
Q1
$132K Sell
13,240
-94,418
-88% -$1.36M ﹤0.01% 2469
2013
Q4
$1.4M Sell
107,658
-339,798
-76% -$4.68M 0.02% 611
2013
Q3
$6.68M Buy
447,456
+267,876
+149% +$3.21M 0.08% 184
2013
Q2
$1.68M Buy
+179,580
New +$1.22M 0.03% 542

Other funds holding RPTP

Jane Street's RPTP Position: Q3 2016 in Review

Jane Street sold out of RAPTOR PHARMACEUTICAL CORP COM STK (DE) (RPTP) in Q3 2016, closing a stake of 14,050 shares — an estimated $75K sold.

Jane Street first reported a position in RPTP in Q2 2013 and held it in 12 quarters. The position peaked at $6.68M in Q3 2013. 111 funds tracked by Wall St. Rank hold RPTP as of Q3 2016.

  • Jane Street reported no remaining RAPTOR PHARMACEUTICAL CORP COM STK (DE) position as of Q3 2016 after selling out during the quarter.
  • Jane Street sold 14,050 RAPTOR PHARMACEUTICAL CORP COM STK (DE) shares in Q3 2016, an estimated $75K.
  • Jane Street first reported a position in RAPTOR PHARMACEUTICAL CORP COM STK (DE) in Q2 2013 and held it in 12 quarters.
  • Jane Street's RAPTOR PHARMACEUTICAL CORP COM STK (DE) position peaked at $6.68M in Q3 2013.
  • 111 funds tracked by Wall St. Rank held RAPTOR PHARMACEUTICAL CORP COM STK (DE) as of Q3 2016.

Based on Jane Street's 13F filing for Q3 2016, filed 15 Nov 2016.